HK2 and ovarian cancer: To understand how TRPM7 modulated metabolic reprogramming in ovarian cancer, we analyzed the expression of TRPM7, glycolysis-related HK2, PDK1, and OXPHOS-related IDH3B and UQCRC1 in 60 ovarian cancer tissues by IHC (Fig. 3A).